The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus

被引:81
作者
Goulding, NJ [1 ]
机构
[1] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England
关键词
D O I
10.1016/j.coph.2004.06.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glucocorticoids have been the mainstay of anti-inflammatory therapy for the past 50 years despite the significant risks associated with their long-term use. Recent research into the molecular mechanisms of action of these compounds can be aggregated into two major themes: first, those that focus on the involvement of the glucocorticoid receptor in regulating the transcription of pro-inflammatory genes; and second, studies that seek to identify alternative pathways of glucocorticoid action either via the induction of anti-inflammatory mediators or through rapid non-genomic mechanisms. Understanding the temporal-spatial patterns of these multiple mechanisms on relevant cell types will be key to explaining the profound effects that these four-ring steroids exert on the inflammatory process.
引用
收藏
页码:629 / 636
页数:8
相关论文
共 46 条
[1]   Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis [J].
Baeten, D ;
Moller, HJ ;
Delanghe, J ;
Veys, EM ;
Moestrup, SK ;
De Keyser, F .
ARTHRITIS AND RHEUMATISM, 2004, 50 (05) :1611-1623
[2]   Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase [J].
Barnes, PJ ;
Ito, K ;
Adcock, IM .
LANCET, 2004, 363 (9410) :731-733
[3]   How do corticosteroids work in asthma? [J].
Barnes, PJ ;
Adcock, IM .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (05) :359-370
[4]   Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis [J].
Bartholome, B ;
Spies, CM ;
Gaber, T ;
Schuchmann, S ;
Berki, T ;
Kunkel, D ;
Bienert, M ;
Radbruch, A ;
Burmester, GR ;
Lauster, R ;
Scheffold, A ;
Buttgereit, F .
FASEB JOURNAL, 2004, 18 (01) :70-80
[5]   New glucocorticosteroids with an improved therapeutic ratio? [J].
Belvisi, MG ;
Brown, TJ ;
Wicks, S ;
Foster, ML .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2001, 14 (03) :221-227
[6]   Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity [J].
Belvisi, MG ;
Wicks, SL ;
Battram, CH ;
Bottoms, SEW ;
Redford, JE ;
Woodman, P ;
Brown, TJ ;
Webber, SE ;
Foster, ML .
JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :1975-1982
[7]   Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10 [J].
Berrebi, D ;
Bruscoli, S ;
Cohen, N ;
Foussat, A ;
Migliorati, G ;
Bouchet-Delbos, L ;
Maillot, MC ;
Portier, A ;
Couderc, J ;
Galanaud, P ;
Peuchmaur, M ;
Riccardi, C ;
Emilie, D .
BLOOD, 2003, 101 (02) :729-738
[8]   Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition [J].
Bledsoe, RK ;
Montana, VG ;
Stanley, TB ;
Delves, CJ ;
Apolito, CJ ;
McKee, DD ;
Consler, TG ;
Parks, DJ ;
Stewart, EL ;
Willson, TM ;
Lambert, MH ;
Moore, JT ;
Pearce, KH ;
Xu, HE .
CELL, 2002, 110 (01) :93-105
[9]   Editorial: Glucocorticoid action networks - An introduction to systems biology [J].
Chrousos, GP ;
Charmandari, E ;
Kino, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :563-564
[10]   Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways [J].
Clark, AR ;
Lasa, M .
CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (04) :404-411